Mon–Fri 8AM–5PM · Telehealth Available
VerityMD Neurology accepts new patient referrals by fax: (916) 244-3875
Some patients with mild cognitive impairment or early Alzheimer’s disease may ask whether newer disease-modifying therapies such as anti-amyloid treatments could be appropriate.
VerityMD Neurology provides careful clinical review for Alzheimer’s disease diagnosis, cognitive stage, MRI safety, biomarker confirmation, medication risks, and shared decision-making when advanced treatment evaluation is clinically appropriate.

Mild memory loss
Mild cognitive impairment
Early Alzheimer’s disease diagnosis
Family concern about progression
Interest in anti-amyloid therapy discussion
Need for biomarker or MRI review
Questions about benefits, risks, and monitoring
Mild cognitive impairment due to Alzheimer’s disease when supported by workup
Early Alzheimer’s disease
Amyloid-positive cognitive impairment
Cognitive symptoms requiring further diagnostic clarification
Patients needing careful risk review before advanced therapy consideration
Candidacy review includes cognitive stage, diagnosis, functional status, medical history, bleeding risk, anticoagulant use, MRI findings, and patient/family goals.
How this helps:
Clarifies whether further evaluation is appropriate
Identifies safety concerns
Supports realistic shared decision-making
Advanced therapy decisions may require amyloid confirmation and MRI review.
How this helps:
Helps confirm whether Alzheimer’s biology is present
Reviews ARIA and MRI-related safety considerations
Guides treatment pathway planning
Anti-amyloid treatment requires discussion of potential benefits, risks, infusion logistics, MRI monitoring, and family support.
How this helps:
Helps patients and families understand tradeoffs
Supports safer monitoring
Clarifies expectations and responsibilities
Mild cognitive impairment or early dementia with concern for Alzheimer’s disease
Interest in Leqembi or anti-amyloid therapy
Need for amyloid PET/CSF biomarker discussion
Need for MRI safety review
Family wants structured counseling about risks and benefits
Referral from PCP, specialist, or referring provider
Medication list, including over-the-counter medications and supplements
Relevant office notes, hospital records, imaging reports, labs, and prior neurological testing if available
Prior cognitive testing
Amyloid PET/CSF results if available
Brain MRI reports and images if available
Medication list including anticoagulants/antiplatelets
APOE results if available
This page is for patient education and does not replace individualized medical advice. Testing and treatment decisions should be based on the patient’s history, examination, records, medications, insurance requirements, and clinical judgment.

Call 911 or go to the nearest emergency department for:
Sudden weakness, facial droop, trouble speaking, or new vision loss
Severe sudden headache or rapidly worsening neurological symptoms
Loss of consciousness, seizure, chest pain, or severe shortness of breath
New inability to walk or sudden severe dizziness with stroke-like symptoms
VerityMD Neurology accepts new patient referrals by fax from the patient’s primary care physician, specialist, or referring provider’s office. To ensure accurate triage, insurance verification, and appropriate scheduling, referrals should be sent directly from the referring provider’s office.
Patients who would like to be seen at VerityMD Neurology should contact their PCP, specialist, or referring provider and ask them to fax a neurology referral with relevant clinical notes, insurance information, medication list, imaging reports, lab results, and prior neurology records if available.




Phone: (916) 500-4989
Fax Referral: (916) 244-3875
Mon-Fri: 8:00 AM–12:00 PM and 1:00 PM–5:00 PM
Closed for lunch: 12:00 PM–1:00 PM
Sat–Sun: Closed
Copyright 2026. VerityMD Inc. All Rights Reserved.
Terms and conditions | Privacy Policy | Powered by Get Top Listed Inc.